BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 77145)

  • 1. Recent advances in antitumor antibiotics.
    Umezawa H
    Antibiot Chemother (1971); 1978; 23():76-87. PubMed ID: 77145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the mechanism of reductive activation in the mode of action of some anticancer drugs.
    Favaudon V
    Biochimie; 1982 Jul; 64(7):457-75. PubMed ID: 6181817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anthracycline antineoplastic drugs.
    Young RC; Ozols RF; Myers CE
    N Engl J Med; 1981 Jul; 305(3):139-53. PubMed ID: 7017406
    [No Abstract]   [Full Text] [Related]  

  • 4. Biochemical parameters of growth inhibition of human leukemia cells by antitumor anthracycline agents.
    Schwartz HS; Kanter PM
    Cancer Treat Rep; 1979 May; 63(5):821-5. PubMed ID: 287555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental evaluation of anthracycline analogs.
    Casazza AM
    Cancer Treat Rep; 1979 May; 63(5):835-44. PubMed ID: 455325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Future clinical investigations with anthracycline antibiotics in relation to daunorubicin.
    Muggia FM; Blum RH; Wernz JC
    Cancer Treat Rep; 1981; 65 Suppl 4():35-7. PubMed ID: 6955012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives.
    Young CW; Raymond V
    Cancer Treat Rep; 1986 Jan; 70(1):51-63. PubMed ID: 2935251
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of antineoplastic agents by pharmaceutical companies.
    Crooke ST
    Fed Proc; 1979 Jan; 38(1):108-12. PubMed ID: 83251
    [No Abstract]   [Full Text] [Related]  

  • 9. Some antineoplastic antibiotics.
    Cheng CC; Zee-Cheng KY
    J Pharm Sci; 1972 Apr; 61(4):485-501. PubMed ID: 4111335
    [No Abstract]   [Full Text] [Related]  

  • 10. Mutagenicity of aclacinomycin A and daunomycin derivatives.
    Umezawa K; Sawamura M; Matsushima T; Sugimura T
    Cancer Res; 1978 Jun; 38(6):1782-4. PubMed ID: 348304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of antineoplastic antibiotics and DNA.
    Gause GF; Dudnik YV
    Antibiot Chemother (1971); 1980; 28():102-8. PubMed ID: 6158286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zinostatin (neocarzinostatin).
    Issell BF; Prestayko AW; Comis RL; Crooke ST
    Cancer Treat Rev; 1979 Dec; 6(4):239-49. PubMed ID: 161199
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of various new antibiotics in the therapy of tumors].
    Zdichynec B
    Vnitr Lek; 1972 Sep; 18(9):921-2. PubMed ID: 4116536
    [No Abstract]   [Full Text] [Related]  

  • 14. [Secondary microbial metabolites with potentials for antineoplastic actions: antineoplastic antibiotics and immunopotentiators].
    Umezawa H
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1071-86. PubMed ID: 6191672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I and II agents in cancer therapy: I. Anthracyclines and related compounds.
    Wadler S; Fuks JZ; Wiernik PH
    J Clin Pharmacol; 1986; 26(7):491-509. PubMed ID: 2944917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New anthracycline antibiotic aclacinomycin A: experimental studies and correlations with clinical trials.
    Oki T; Takeuchi T; Oka S; Umezawa H
    Recent Results Cancer Res; 1981; 76():21-40. PubMed ID: 6940212
    [No Abstract]   [Full Text] [Related]  

  • 17. [Chemotherapy of invasive tumors. VI. Antibiotics].
    Beran M; Semonský M; Semonská S
    Cesk Farm; 1979 Dec; 28(9-10):411-20. PubMed ID: 95184
    [No Abstract]   [Full Text] [Related]  

  • 18. DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA.
    Bodley A; Liu LF; Israel M; Seshadri R; Koseki Y; Giuliani FC; Kirschenbaum S; Silber R; Potmesil M
    Cancer Res; 1989 Nov; 49(21):5969-78. PubMed ID: 2551497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental chemotherapy of malignant tumors in combination with short-term general hypoxia].
    Kolganov AS
    Vopr Onkol; 2001; 47(1):81-5. PubMed ID: 11317544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental and clinical activity of a new anthracycline derivative: detorubicin (14-diethoxyacetoxydaunorubicin).
    Maral R; Heusse D; Lavelle F; Cueille G; Marlard M; Jacquillat C; Maral J; Auclerc MF; Weil M; Auclerc G; Bernard J
    Recent Results Cancer Res; 1980; 74():172-83. PubMed ID: 7444138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.